China is starting work on a new facility that will house the country’s first comprehensive regenerative medicine technology center and Asia’s largest stem cell bank.
The Stem Cell Regenerative Medicine Industrial Project of National Bio-Industry Base (NBPD) is part of a multistage project aimed at providing a central research zone for China’s regenerative medicine and biomedical industry.
The work was started by the Jiangsu government’s China Medical City and Shenzhen Beike Biotechnology, which hope that the facility will lay the foundations for China to develop into a world leader in the biotechnology industry.
Pharmaceutical Technology reports that the facility, which will be located in Taizhou, will house four centres: a technology transfer centre to help take research to the clinic, a testing centre, a clinical support service centre and Asia’s largest stem cell bank.